Editas Medicine (EDIT) Other Non-Current Liabilities (2015 - 2025)

Editas Medicine (EDIT) has 9 years of Other Non-Current Liabilities data on file, last reported at $2.8 million in Q4 2025.

• Other Non-Current Liabilities for Q4 2025 came in at $2.8 million, down 8.37% year-over-year; the trailing twelve-month figure through Dec 2025 was $2.8 million (down 8.37% YoY), and the FY2025 annual result was $2.8 million, down 8.37% from the prior year.
• Other Non-Current Liabilities declined to $2.8 million in Q4 2025 per EDIT's latest filing, from $4.7 million in the prior quarter.
• Over five years, Other Non-Current Liabilities peaked at $6.4 million in Q1 2025 and troughed at $1.8 million in Q4 2023.
• A 3-year average of $3.8 million and a median of $3.5 million in 2024 frame the typical range for Other Non-Current Liabilities.
• On a YoY basis, Other Non-Current Liabilities climbed as much as 83.21% in 2025 and fell as far as 8.37% in 2025.
• A 3-year view of Other Non-Current Liabilities shows it stood at $1.8 million in 2023, then soared by 70.67% to $3.1 million in 2024, then dropped by 8.37% to $2.8 million in 2025.
• Business Quant data shows EDIT's Other Non-Current Liabilities at $2.8 million in Q4 2025, $4.7 million in Q3 2025, and $4.6 million in Q2 2025.